ACRV (STOCKS)
Acrivon Therapeutics, Inc. Common Stock
$1.750000
+0.030000 (+1.74%)
Prev close: $1.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Peter Blume-Jensen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $86.83M
- Employees
- 78
- P/E (TTM)
- -0.86
- P/B (TTM)
- 0.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.49 | $-0.54 | +0.0459 | +8.57% |
|
Dec 2025 (Q4)
|
$-0.52 | $-0.48 | -0.0444 | -9.34% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.60 | +0.1318 | +21.90% |
|
Jun 2025 (Q2)
|
$-0.55 | $-0.60 | +0.0480 | +8.03% |